nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—Azoospermia—Cisplatin—esophageal cancer	0.0168	0.0588	CcSEcCtD
Testosterone Propionate—Glucose tolerance impaired—Cisplatin—esophageal cancer	0.0168	0.0588	CcSEcCtD
Testosterone Propionate—Oligospermia—Methotrexate—esophageal cancer	0.0119	0.0414	CcSEcCtD
Testosterone Propionate—Cognitive impairment—Methotrexate—esophageal cancer	0.00953	0.0333	CcSEcCtD
Testosterone Propionate—Azoospermia—Methotrexate—esophageal cancer	0.00924	0.0322	CcSEcCtD
Testosterone Propionate—Cognitive disorder—Methotrexate—esophageal cancer	0.00575	0.0201	CcSEcCtD
Testosterone Propionate—Hirsutism—Capecitabine—esophageal cancer	0.00575	0.0201	CcSEcCtD
Testosterone Propionate—Pain—Carboplatin—esophageal cancer	0.00472	0.0165	CcSEcCtD
Testosterone Propionate—Coagulopathy—Capecitabine—esophageal cancer	0.00429	0.015	CcSEcCtD
Testosterone Propionate—Hydrocortisone—ANXA1—esophageal cancer	0.00384	0.105	CrCbGaD
Testosterone Propionate—Nandrolone phenpropionate—CYP19A1—esophageal cancer	0.00384	0.105	CrCbGaD
Testosterone Propionate—Testolactone—CYP19A1—esophageal cancer	0.00366	0.0999	CrCbGaD
Testosterone Propionate—Inflammation—Capecitabine—esophageal cancer	0.00345	0.012	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.0034	0.0119	CcSEcCtD
Testosterone Propionate—Norgestimate—ABCC2—esophageal cancer	0.00336	0.0916	CrCbGaD
Testosterone Propionate—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00329	0.0115	CcSEcCtD
Testosterone Propionate—Drostanolone—CYP19A1—esophageal cancer	0.00327	0.089	CrCbGaD
Testosterone Propionate—Irritability—Cisplatin—esophageal cancer	0.00314	0.011	CcSEcCtD
Testosterone Propionate—Neoplasm—Capecitabine—esophageal cancer	0.00302	0.0105	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—XRCC3—esophageal cancer	0.00297	0.00445	CbGpPWpGaD
Testosterone Propionate—Breast disorder—Cisplatin—esophageal cancer	0.00297	0.0104	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—GSTO1—esophageal cancer	0.00297	0.00444	CbGpPWpGaD
Testosterone Propionate—Nandrolone decanoate—CYP19A1—esophageal cancer	0.00291	0.0794	CrCbGaD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTO1—esophageal cancer	0.00289	0.00432	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—SLC39A6—esophageal cancer	0.00285	0.00426	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GSTO1—esophageal cancer	0.00285	0.00426	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—ADH7—esophageal cancer	0.00272	0.00406	CbGpPWpGaD
Testosterone Propionate—Libido decreased—Capecitabine—esophageal cancer	0.00262	0.00913	CcSEcCtD
Testosterone Propionate—Increased appetite—Capecitabine—esophageal cancer	0.00258	0.00901	CcSEcCtD
Testosterone Propionate—Inflammation—Methotrexate—esophageal cancer	0.00257	0.00895	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Capecitabine—esophageal cancer	0.00254	0.00886	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.00252	0.00377	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—BAX—esophageal cancer	0.0025	0.00373	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—ALDH2—esophageal cancer	0.00246	0.00367	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00243	0.00847	CcSEcCtD
Testosterone Propionate—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00241	0.0084	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Cisplatin—esophageal cancer	0.0024	0.00837	CcSEcCtD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTT1—esophageal cancer	0.00239	0.00358	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—HIF1A—esophageal cancer	0.00239	0.00357	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—ADH7—esophageal cancer	0.00238	0.00356	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CALR—esophageal cancer	0.00236	0.00354	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—ALDH2—esophageal cancer	0.00235	0.00352	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—GSTT1—esophageal cancer	0.00234	0.00349	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00232	0.00347	CbGpPWpGaD
Testosterone Propionate—Irritability—Capecitabine—esophageal cancer	0.00232	0.00808	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—CYP2A6—esophageal cancer	0.00231	0.00345	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—KDR—esophageal cancer	0.00228	0.00342	CbGpPWpGaD
Testosterone Propionate—Neoplasm—Methotrexate—esophageal cancer	0.00225	0.00785	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Cisplatin—esophageal cancer	0.00225	0.00785	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Capecitabine—esophageal cancer	0.00224	0.00782	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Cisplatin—esophageal cancer	0.00224	0.00781	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTT1—esophageal cancer	0.00224	0.00335	CbGpPWpGaD
Testosterone Propionate—Urethral disorder—Cisplatin—esophageal cancer	0.00223	0.00779	CcSEcCtD
Testosterone Propionate—Gynaecomastia—Methotrexate—esophageal cancer	0.00223	0.00777	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP2A6—esophageal cancer	0.00221	0.00331	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—RUNX3—esophageal cancer	0.0022	0.00329	CbGpPWpGaD
Testosterone Propionate—Breast disorder—Capecitabine—esophageal cancer	0.00219	0.00765	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—PTGS1—esophageal cancer	0.00219	0.00327	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00218	0.00326	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—NOTCH1—esophageal cancer	0.00215	0.00322	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—PTGS1—esophageal cancer	0.0021	0.00314	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—ADH1B—esophageal cancer	0.00209	0.00312	CbGpPWpGaD
Testosterone Propionate—Immune system disorder—Cisplatin—esophageal cancer	0.00206	0.00718	CcSEcCtD
Testosterone Propionate—AR—FOXA1 transcription factor network—CREBBP—esophageal cancer	0.00206	0.00308	CbGpPWpGaD
Testosterone Propionate—Mediastinal disorder—Cisplatin—esophageal cancer	0.00205	0.00716	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—GAPDH—esophageal cancer	0.00203	0.00303	CbGpPWpGaD
Testosterone Propionate—Alopecia—Cisplatin—esophageal cancer	0.00201	0.00702	CcSEcCtD
Testosterone Propionate—Malnutrition—Cisplatin—esophageal cancer	0.00198	0.00692	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—ABCC2—esophageal cancer	0.00197	0.00295	CbGpPWpGaD
Testosterone Propionate—Dysuria—Capecitabine—esophageal cancer	0.00196	0.00684	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.00196	0.00293	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.00196	0.00293	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—CREBBP—esophageal cancer	0.00195	0.00292	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—RB1—esophageal cancer	0.00194	0.00291	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP26A1—esophageal cancer	0.00194	0.0029	CbGpPWpGaD
Testosterone Propionate—Levonorgestrel—CYP19A1—esophageal cancer	0.00194	0.0528	CrCbGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00191	0.00286	CbGpPWpGaD
Testosterone Propionate—Weight increased—Capecitabine—esophageal cancer	0.00191	0.00666	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—SMAD4—esophageal cancer	0.00189	0.00282	CbGpPWpGaD
Testosterone Propionate—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00187	0.00651	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—CYP1B1—esophageal cancer	0.00186	0.00278	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Cisplatin—esophageal cancer	0.00184	0.00642	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00184	0.00275	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—NFE2L2—esophageal cancer	0.00183	0.00274	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTO1—esophageal cancer	0.0018	0.0027	CbGpPWpGaD
Testosterone Propionate—Spironolactone—ABCC2—esophageal cancer	0.0018	0.049	CrCbGaD
Testosterone Propionate—Malaise—Cisplatin—esophageal cancer	0.00179	0.00624	CcSEcCtD
Testosterone Propionate—Haematuria—Capecitabine—esophageal cancer	0.00178	0.00622	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP1B1—esophageal cancer	0.00178	0.00267	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTO1—esophageal cancer	0.00178	0.00266	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—GNG7—esophageal cancer	0.00178	0.00266	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—CREBBP—esophageal cancer	0.00177	0.00265	CbGpPWpGaD
Testosterone Propionate—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00177	0.00617	CcSEcCtD
Testosterone Propionate—Danazol—CYP19A1—esophageal cancer	0.00176	0.0481	CrCbGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00176	0.00263	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—SMAD4—esophageal cancer	0.00175	0.00262	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—CYP19A1—esophageal cancer	0.00175	0.00262	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00173	0.00258	CbGpPWpGaD
Testosterone Propionate—Irritability—Methotrexate—esophageal cancer	0.00172	0.00602	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00172	0.00257	CbGpPWpGaD
Testosterone Propionate—Myalgia—Cisplatin—esophageal cancer	0.00169	0.00589	CcSEcCtD
Testosterone Propionate—Haemoglobin—Capecitabine—esophageal cancer	0.00169	0.00589	CcSEcCtD
Testosterone Propionate—Anxiety—Cisplatin—esophageal cancer	0.00168	0.00587	CcSEcCtD
Testosterone Propionate—Haemorrhage—Capecitabine—esophageal cancer	0.00168	0.00586	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00168	0.00585	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP19A1—esophageal cancer	0.00168	0.00251	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—ALDH2—esophageal cancer	0.00167	0.00249	CbGpPWpGaD
Testosterone Propionate—Liver function test abnormal—Methotrexate—esophageal cancer	0.00167	0.00582	CcSEcCtD
Testosterone Propionate—Discomfort—Cisplatin—esophageal cancer	0.00167	0.00582	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Capecitabine—esophageal cancer	0.00166	0.00578	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00165	0.00247	CbGpPWpGaD
Testosterone Propionate—Connective tissue disorder—Capecitabine—esophageal cancer	0.00165	0.00576	CcSEcCtD
Testosterone Propionate—Urethral disorder—Capecitabine—esophageal cancer	0.00165	0.00574	CcSEcCtD
Testosterone Propionate—Breast disorder—Methotrexate—esophageal cancer	0.00163	0.0057	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Cisplatin—esophageal cancer	0.00162	0.00565	CcSEcCtD
Testosterone Propionate—Oedema—Cisplatin—esophageal cancer	0.00162	0.00565	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—ANXA1—esophageal cancer	0.00161	0.0024	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CASP8—esophageal cancer	0.00159	0.00238	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Cisplatin—esophageal cancer	0.00159	0.00554	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—CYP2A6—esophageal cancer	0.00158	0.00236	CbGpPWpGaD
Testosterone Propionate—Skin disorder—Cisplatin—esophageal cancer	0.00157	0.00548	CcSEcCtD
Testosterone Propionate—Angiopathy—Capecitabine—esophageal cancer	0.00152	0.00531	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—SST—esophageal cancer	0.00152	0.00228	CbGpPWpGaD
Testosterone Propionate—Immune system disorder—Capecitabine—esophageal cancer	0.00152	0.00529	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Capecitabine—esophageal cancer	0.00151	0.00528	CcSEcCtD
Testosterone Propionate—Methyltestosterone—CYP19A1—esophageal cancer	0.00149	0.0406	CrCbGaD
Testosterone Propionate—Alopecia—Capecitabine—esophageal cancer	0.00148	0.00518	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00147	0.00514	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—ALDH2—esophageal cancer	0.00147	0.0022	CbGpPWpGaD
Testosterone Propionate—Mental disorder—Capecitabine—esophageal cancer	0.00147	0.00513	CcSEcCtD
Testosterone Propionate—Malnutrition—Capecitabine—esophageal cancer	0.00146	0.0051	CcSEcCtD
Testosterone Propionate—Dysuria—Methotrexate—esophageal cancer	0.00146	0.00509	CcSEcCtD
Testosterone Propionate—Paraesthesia—Cisplatin—esophageal cancer	0.00145	0.00507	CcSEcCtD
Testosterone Propionate—Dyspnoea—Cisplatin—esophageal cancer	0.00144	0.00503	CcSEcCtD
Testosterone Propionate—Erectile dysfunction—Methotrexate—esophageal cancer	0.00144	0.00502	CcSEcCtD
Testosterone Propionate—AR—FOXA1 transcription factor network—EP300—esophageal cancer	0.0014	0.00209	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTT1—esophageal cancer	0.0014	0.00209	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CHEK2—esophageal cancer	0.0014	0.00209	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.0014	0.00487	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CDKN2A—esophageal cancer	0.00139	0.00207	CbGpPWpGaD
Testosterone Propionate—Pain—Cisplatin—esophageal cancer	0.00138	0.00483	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP2A6—esophageal cancer	0.00138	0.00207	CbGpPWpGaD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—PIK3CA—esophageal cancer	0.00137	0.00205	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Capecitabine—esophageal cancer	0.00136	0.00473	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Cisplatin—esophageal cancer	0.00133	0.00465	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.00133	0.00199	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—EP300—esophageal cancer	0.00133	0.00199	CbGpPWpGaD
Testosterone Propionate—Haematuria—Methotrexate—esophageal cancer	0.00133	0.00463	CcSEcCtD
Testosterone Propionate—Malaise—Capecitabine—esophageal cancer	0.00132	0.0046	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00132	0.00459	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—PTGS1—esophageal cancer	0.00131	0.00196	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CYP19A1—esophageal cancer	0.00131	0.00196	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—CREBBP—esophageal cancer	0.00126	0.00189	CbGpPWpGaD
Testosterone Propionate—Hypertension—Capecitabine—esophageal cancer	0.00126	0.0044	CcSEcCtD
Testosterone Propionate—Haemoglobin—Methotrexate—esophageal cancer	0.00126	0.00438	CcSEcCtD
Testosterone Propionate—Haemorrhage—Methotrexate—esophageal cancer	0.00125	0.00436	CcSEcCtD
Testosterone Propionate—Progesterone—CYP1B1—esophageal cancer	0.00125	0.034	CrCbGaD
Testosterone Propionate—Arthralgia—Capecitabine—esophageal cancer	0.00124	0.00434	CcSEcCtD
Testosterone Propionate—Myalgia—Capecitabine—esophageal cancer	0.00124	0.00434	CcSEcCtD
Testosterone Propionate—Anxiety—Capecitabine—esophageal cancer	0.00124	0.00433	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00124	0.00431	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Methotrexate—esophageal cancer	0.00123	0.00431	CcSEcCtD
Testosterone Propionate—Discomfort—Capecitabine—esophageal cancer	0.00123	0.00429	CcSEcCtD
Testosterone Propionate—Urethral disorder—Methotrexate—esophageal cancer	0.00122	0.00427	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.00122	0.00182	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TGFBR2—esophageal cancer	0.00121	0.00181	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—EP300—esophageal cancer	0.00121	0.0018	CbGpPWpGaD
Testosterone Propionate—Confusional state—Capecitabine—esophageal cancer	0.0012	0.0042	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.0012	0.0018	CbGpPWpGaD
Testosterone Propionate—Oedema—Capecitabine—esophageal cancer	0.00119	0.00416	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Cisplatin—esophageal cancer	0.00119	0.00416	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—ABL1—esophageal cancer	0.00118	0.00177	CbGpPWpGaD
Testosterone Propionate—Testosterone—CYP1B1—esophageal cancer	0.00118	0.0321	CrCbGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CCND1—esophageal cancer	0.00117	0.00175	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CREBBP—esophageal cancer	0.00117	0.00175	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Capecitabine—esophageal cancer	0.00117	0.00408	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—RB1—esophageal cancer	0.00117	0.00174	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00116	0.00174	CbGpPWpGaD
Testosterone Propionate—Asthenia—Cisplatin—esophageal cancer	0.00116	0.00405	CcSEcCtD
Testosterone Propionate—Skin disorder—Capecitabine—esophageal cancer	0.00116	0.00404	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.00116	0.00173	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—SMAD4—esophageal cancer	0.00115	0.00172	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Methotrexate—esophageal cancer	0.00113	0.00396	CcSEcCtD
Testosterone Propionate—Immune system disorder—Methotrexate—esophageal cancer	0.00113	0.00394	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Methotrexate—esophageal cancer	0.00113	0.00393	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—esophageal cancer	0.00112	0.00167	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP1B1—esophageal cancer	0.00112	0.00167	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Cisplatin—esophageal cancer	0.00111	0.00386	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—TGFBR2—esophageal cancer	0.00111	0.00165	CbGpPWpGaD
Testosterone Propionate—Alopecia—Methotrexate—esophageal cancer	0.0011	0.00385	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP1B1—esophageal cancer	0.0011	0.00164	CbGpPWpGaD
Testosterone Propionate—Mental disorder—Methotrexate—esophageal cancer	0.00109	0.00382	CcSEcCtD
Testosterone Propionate—Drospirenone—PTGS2—esophageal cancer	0.00109	0.0297	CrCbGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—HMOX1—esophageal cancer	0.00109	0.00163	CbGpPWpGaD
Testosterone Propionate—Malnutrition—Methotrexate—esophageal cancer	0.00109	0.0038	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00109	0.00379	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BAX—esophageal cancer	0.00109	0.00162	CbGpPWpGaD
Testosterone Propionate—Insomnia—Capecitabine—esophageal cancer	0.00108	0.00376	CcSEcCtD
Testosterone Propionate—Paraesthesia—Capecitabine—esophageal cancer	0.00107	0.00374	CcSEcCtD
Testosterone Propionate—Dyspnoea—Capecitabine—esophageal cancer	0.00106	0.00371	CcSEcCtD
Testosterone Propionate—Megestrol acetate—ABCB1—esophageal cancer	0.00106	0.029	CrCbGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP19A1—esophageal cancer	0.00105	0.00157	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00103	0.00155	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00103	0.00359	CcSEcCtD
Testosterone Propionate—Vomiting—Cisplatin—esophageal cancer	0.00103	0.00359	CcSEcCtD
Testosterone Propionate—Fatigue—Capecitabine—esophageal cancer	0.00103	0.00359	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.00102	0.00153	CbGpPWpGaD
Testosterone Propionate—Rash—Cisplatin—esophageal cancer	0.00102	0.00356	CcSEcCtD
Testosterone Propionate—Pain—Capecitabine—esophageal cancer	0.00102	0.00356	CcSEcCtD
Testosterone Propionate—Dermatitis—Cisplatin—esophageal cancer	0.00102	0.00356	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00101	0.00152	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Methotrexate—esophageal cancer	0.00101	0.00352	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—NR1I2—esophageal cancer	0.000998	0.00149	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Capecitabine—esophageal cancer	0.000983	0.00343	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000981	0.00147	CbGpPWpGaD
Testosterone Propionate—Malaise—Methotrexate—esophageal cancer	0.000981	0.00342	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000975	0.0034	CcSEcCtD
Testosterone Propionate—Nausea—Cisplatin—esophageal cancer	0.000961	0.00335	CcSEcCtD
Testosterone Propionate—Progesterone—CYP2A6—esophageal cancer	0.00096	0.0262	CrCbGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.00095	0.00142	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.00095	0.00142	CbGpPWpGaD
Testosterone Propionate—Urticaria—Capecitabine—esophageal cancer	0.000947	0.00331	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—esophageal cancer	0.000943	0.00141	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Capecitabine—esophageal cancer	0.000943	0.00329	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—BLVRB—esophageal cancer	0.00094	0.00141	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SLC52A3—esophageal cancer	0.00094	0.00141	CbGpPWpGaD
Testosterone Propionate—Arthralgia—Methotrexate—esophageal cancer	0.000926	0.00323	CcSEcCtD
Testosterone Propionate—Myalgia—Methotrexate—esophageal cancer	0.000926	0.00323	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00092	0.00321	CcSEcCtD
Testosterone Propionate—Discomfort—Methotrexate—esophageal cancer	0.000915	0.00319	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000914	0.00137	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—esophageal cancer	0.000903	0.00135	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—SLC52A3—esophageal cancer	0.000901	0.00135	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—BLVRB—esophageal cancer	0.000901	0.00135	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000899	0.00134	CbGpPWpGaD
Testosterone Propionate—Confusional state—Methotrexate—esophageal cancer	0.000895	0.00312	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Methotrexate—esophageal cancer	0.000888	0.0031	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Capecitabine—esophageal cancer	0.000879	0.00307	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Methotrexate—esophageal cancer	0.000871	0.00304	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—esophageal cancer	0.000868	0.0013	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CCND1—esophageal cancer	0.000866	0.00129	CbGpPWpGaD
Testosterone Propionate—Testosterone—CYP19A1—esophageal cancer	0.000864	0.0236	CrCbGaD
Testosterone Propionate—Skin disorder—Methotrexate—esophageal cancer	0.000862	0.00301	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—esophageal cancer	0.000859	0.00129	CbGpPWpGaD
Testosterone Propionate—Asthenia—Capecitabine—esophageal cancer	0.000856	0.00299	CcSEcCtD
Testosterone Propionate—Pruritus—Capecitabine—esophageal cancer	0.000844	0.00294	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CDKN1A—esophageal cancer	0.000838	0.00125	CbGpPWpGaD
Testosterone Propionate—COMT—bronchus—esophageal cancer	0.000829	0.101	CbGeAlD
Testosterone Propionate—Diarrhoea—Capecitabine—esophageal cancer	0.000816	0.00285	CcSEcCtD
Testosterone Propionate—COMT—smooth muscle tissue—esophageal cancer	0.000811	0.0993	CbGeAlD
Testosterone Propionate—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000809	0.00282	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000805	0.0012	CbGpPWpGaD
Testosterone Propionate—Insomnia—Methotrexate—esophageal cancer	0.000803	0.0028	CcSEcCtD
Testosterone Propionate—UGT1A1—digestive system—esophageal cancer	0.000801	0.098	CbGeAlD
Testosterone Propionate—COMT—Metabolism—CA1—esophageal cancer	0.0008	0.0012	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SLC10A2—esophageal cancer	0.0008	0.0012	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Methotrexate—esophageal cancer	0.000797	0.00278	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—EP300—esophageal cancer	0.000797	0.00119	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Methotrexate—esophageal cancer	0.000792	0.00276	CcSEcCtD
Testosterone Propionate—Dizziness—Capecitabine—esophageal cancer	0.000789	0.00275	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CASP8—esophageal cancer	0.00077	0.00115	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000766	0.00267	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—SLC10A2—esophageal cancer	0.000766	0.00115	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CA1—esophageal cancer	0.000766	0.00115	CbGpPWpGaD
Testosterone Propionate—Fatigue—Methotrexate—esophageal cancer	0.000765	0.00267	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—RB1—esophageal cancer	0.000764	0.00114	CbGpPWpGaD
Testosterone Propionate—Pain—Methotrexate—esophageal cancer	0.000759	0.00265	CcSEcCtD
Testosterone Propionate—Vomiting—Capecitabine—esophageal cancer	0.000758	0.00265	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—esophageal cancer	0.000756	0.00113	CbGpPWpGaD
Testosterone Propionate—Rash—Capecitabine—esophageal cancer	0.000752	0.00262	CcSEcCtD
Testosterone Propionate—Dermatitis—Capecitabine—esophageal cancer	0.000751	0.00262	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—esophageal cancer	0.000749	0.00112	CbGpPWpGaD
Testosterone Propionate—Headache—Capecitabine—esophageal cancer	0.000747	0.00261	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000747	0.00112	CbGpPWpGaD
Testosterone Propionate—COMT—trachea—esophageal cancer	0.000744	0.0911	CbGeAlD
Testosterone Propionate—Feeling abnormal—Methotrexate—esophageal cancer	0.000732	0.00255	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—CA2—esophageal cancer	0.000731	0.00109	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000726	0.00253	CcSEcCtD
Testosterone Propionate—Nausea—Capecitabine—esophageal cancer	0.000708	0.00247	CcSEcCtD
Testosterone Propionate—Urticaria—Methotrexate—esophageal cancer	0.000705	0.00246	CcSEcCtD
Testosterone Propionate—Abdominal pain—Methotrexate—esophageal cancer	0.000702	0.00245	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—CA2—esophageal cancer	0.0007	0.00105	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000684	0.00102	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PLCE1—esophageal cancer	0.00068	0.00102	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ADH7—esophageal cancer	0.00068	0.00102	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—EGFR—esophageal cancer	0.000679	0.00102	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BCL2—esophageal cancer	0.000661	0.000988	CbGpPWpGaD
Testosterone Propionate—Spironolactone—ABCB1—esophageal cancer	0.000661	0.018	CrCbGaD
Testosterone Propionate—Hypersensitivity—Methotrexate—esophageal cancer	0.000654	0.00228	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—ADH7—esophageal cancer	0.000651	0.000974	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PLCE1—esophageal cancer	0.000651	0.000974	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000644	0.000963	CbGpPWpGaD
Testosterone Propionate—COMT—digestive system—esophageal cancer	0.00064	0.0784	CbGeAlD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.000638	0.000954	CbGpPWpGaD
Testosterone Propionate—Asthenia—Methotrexate—esophageal cancer	0.000637	0.00222	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000635	0.00095	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—SMG6—esophageal cancer	0.000634	0.000949	CbGpPWpGaD
Testosterone Propionate—Pruritus—Methotrexate—esophageal cancer	0.000628	0.00219	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000627	0.000938	CbGpPWpGaD
Testosterone Propionate—AR—epithelium—esophageal cancer	0.000616	0.0754	CbGeAlD
Testosterone Propionate—Norethindrone—ABCB1—esophageal cancer	0.000613	0.0167	CrCbGaD
Testosterone Propionate—Diarrhoea—Methotrexate—esophageal cancer	0.000607	0.00212	CcSEcCtD
Testosterone Propionate—AR—bronchus—esophageal cancer	0.000606	0.0742	CbGeAlD
Testosterone Propionate—COMT—Metabolism—ADH1B—esophageal cancer	0.000596	0.000892	CbGpPWpGaD
Testosterone Propionate—AR—smooth muscle tissue—esophageal cancer	0.000593	0.0726	CbGeAlD
Testosterone Propionate—Dizziness—Methotrexate—esophageal cancer	0.000587	0.00205	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—ADH1B—esophageal cancer	0.000571	0.000854	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TYMP—esophageal cancer	0.00057	0.000852	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CCND1—esophageal cancer	0.000567	0.000848	CbGpPWpGaD
Testosterone Propionate—Vomiting—Methotrexate—esophageal cancer	0.000564	0.00197	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—SLC52A3—esophageal cancer	0.000563	0.000843	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—BLVRB—esophageal cancer	0.000563	0.000843	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000562	0.000841	CbGpPWpGaD
Testosterone Propionate—Rash—Methotrexate—esophageal cancer	0.00056	0.00195	CcSEcCtD
Testosterone Propionate—Dermatitis—Methotrexate—esophageal cancer	0.000559	0.00195	CcSEcCtD
Testosterone Propionate—Headache—Methotrexate—esophageal cancer	0.000556	0.00194	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—CYP26A1—esophageal cancer	0.000554	0.000829	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000548	0.000819	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TYMP—esophageal cancer	0.000546	0.000816	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ALOX15—esophageal cancer	0.00054	0.000808	CbGpPWpGaD
Testosterone Propionate—COMT—lung—esophageal cancer	0.000535	0.0655	CbGeAlD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000532	0.000796	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP26A1—esophageal cancer	0.000531	0.000794	CbGpPWpGaD
Testosterone Propionate—Nausea—Methotrexate—esophageal cancer	0.000527	0.00184	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—EP300—esophageal cancer	0.000522	0.000781	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.00052	0.000778	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ALOX15—esophageal cancer	0.000517	0.000774	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTO1—esophageal cancer	0.000515	0.000771	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TPI1—esophageal cancer	0.000515	0.000771	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000509	0.000761	CbGpPWpGaD
Testosterone Propionate—CYP17A1—lymph node—esophageal cancer	0.0005	0.0612	CbGeAlD
Testosterone Propionate—COMT—Metabolism—ALDOB—esophageal cancer	0.000494	0.000739	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TPI1—esophageal cancer	0.000493	0.000738	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTO1—esophageal cancer	0.000493	0.000738	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NR1I2—esophageal cancer	0.000481	0.000719	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CA1—esophageal cancer	0.000479	0.000716	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SLC10A2—esophageal cancer	0.000479	0.000716	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GAPDH—esophageal cancer	0.000476	0.000711	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ALDOB—esophageal cancer	0.000473	0.000708	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000472	0.000706	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CRABP1—esophageal cancer	0.000471	0.000705	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.00047	0.000703	CbGpPWpGaD
Testosterone Propionate—AR—digestive system—esophageal cancer	0.000468	0.0574	CbGeAlD
Testosterone Propionate—CYP17A1—Metabolism—GAPDH—esophageal cancer	0.000455	0.000681	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MYC—esophageal cancer	0.000455	0.000681	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000455	0.00068	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CRABP1—esophageal cancer	0.000451	0.000675	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GNG7—esophageal cancer	0.000448	0.00067	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	0.000445	0.000666	CbGpPWpGaD
Testosterone Propionate—Hydrocortisone—ABCB1—esophageal cancer	0.000439	0.012	CrCbGaD
Testosterone Propionate—UGT1A1—Metabolism—CA2—esophageal cancer	0.000438	0.000655	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.000433	0.000647	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GNG7—esophageal cancer	0.000429	0.000642	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ALDH2—esophageal cancer	0.00042	0.000628	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—HIST1H2BM—esophageal cancer	0.000412	0.000617	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ADH7—esophageal cancer	0.000407	0.000609	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PLCE1—esophageal cancer	0.000407	0.000609	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ALDH2—esophageal cancer	0.000402	0.000602	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTT1—esophageal cancer	0.0004	0.000598	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP2A6—esophageal cancer	0.000395	0.000591	CbGpPWpGaD
Testosterone Propionate—AR—lung—esophageal cancer	0.000391	0.0479	CbGeAlD
Testosterone Propionate—CYP17A1—Metabolism—GSTT1—esophageal cancer	0.000383	0.000572	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP2A6—esophageal cancer	0.000378	0.000566	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000377	0.000564	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000377	0.000563	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTGS1—esophageal cancer	0.000374	0.00056	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ENO1—esophageal cancer	0.000374	0.00056	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TP53—esophageal cancer	0.000374	0.000559	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PSME2—esophageal cancer	0.000369	0.000552	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PSME1—esophageal cancer	0.000369	0.000552	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000369	0.000552	CbGpPWpGaD
Testosterone Propionate—COMT—lymph node—esophageal cancer	0.000366	0.0448	CbGeAlD
Testosterone Propionate—CYP17A1—Metabolism—PTGS1—esophageal cancer	0.000359	0.000536	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ENO1—esophageal cancer	0.000359	0.000536	CbGpPWpGaD
Testosterone Propionate—Progesterone—ABCB1—esophageal cancer	0.000357	0.00975	CrCbGaD
Testosterone Propionate—UGT1A1—Metabolism—ADH1B—esophageal cancer	0.000357	0.000534	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PSME2—esophageal cancer	0.000353	0.000528	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PSME1—esophageal cancer	0.000353	0.000528	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000348	0.000521	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TYMP—esophageal cancer	0.000341	0.000511	CbGpPWpGaD
Testosterone Propionate—Testosterone—ABCB1—esophageal cancer	0.000338	0.00921	CrCbGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP26A1—esophageal cancer	0.000332	0.000497	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ALOX15—esophageal cancer	0.000324	0.000484	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.00032	0.000479	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PSME1—esophageal cancer	0.00032	0.000478	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PSME2—esophageal cancer	0.00032	0.000478	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP1B1—esophageal cancer	0.000318	0.000476	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000316	0.000472	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.00031	0.000463	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TPI1—esophageal cancer	0.000309	0.000462	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTO1—esophageal cancer	0.000309	0.000462	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000308	0.000461	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP1B1—esophageal cancer	0.000305	0.000456	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NOTCH3—esophageal cancer	0.000302	0.000451	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP19A1—esophageal cancer	0.000299	0.000448	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ALDOB—esophageal cancer	0.000296	0.000443	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP19A1—esophageal cancer	0.000287	0.000429	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GAPDH—esophageal cancer	0.000285	0.000426	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CRABP1—esophageal cancer	0.000282	0.000422	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—HMOX1—esophageal cancer	0.000273	0.000409	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NOTCH2—esophageal cancer	0.000271	0.000405	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GNG7—esophageal cancer	0.000269	0.000402	CbGpPWpGaD
Testosterone Propionate—AR—lymph node—esophageal cancer	0.000268	0.0328	CbGeAlD
Testosterone Propionate—COMT—Metabolism—ABCB1—esophageal cancer	0.000262	0.000392	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—HMOX1—esophageal cancer	0.000262	0.000391	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000257	0.000384	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ALDH2—esophageal cancer	0.000252	0.000376	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ABCB1—esophageal cancer	0.000251	0.000375	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTT1—esophageal cancer	0.000239	0.000358	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP2A6—esophageal cancer	0.000237	0.000354	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—SMAD4—esophageal cancer	0.000227	0.00034	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ENO1—esophageal cancer	0.000224	0.000335	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTGS1—esophageal cancer	0.000224	0.000335	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PSME1—esophageal cancer	0.000221	0.000331	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PSME2—esophageal cancer	0.000221	0.000331	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP1B1—esophageal cancer	0.000191	0.000285	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.00019	0.000284	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—MYC—esophageal cancer	0.000187	0.00028	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP19A1—esophageal cancer	0.000179	0.000268	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CREBBP—esophageal cancer	0.000175	0.000262	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CREBBP—esophageal cancer	0.000168	0.000251	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NOTCH1—esophageal cancer	0.000168	0.000251	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—HMOX1—esophageal cancer	0.000164	0.000245	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ABCB1—esophageal cancer	0.000157	0.000235	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NOS3—esophageal cancer	0.000157	0.000235	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—CREBBP—esophageal cancer	0.000152	0.000227	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NOS3—esophageal cancer	0.00015	0.000225	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTGS2—esophageal cancer	0.000143	0.000215	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTGS2—esophageal cancer	0.000137	0.000205	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—EP300—esophageal cancer	0.000119	0.000178	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—EP300—esophageal cancer	0.000114	0.000171	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CREBBP—esophageal cancer	0.000105	0.000157	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NOS3—esophageal cancer	9.4e-05	0.000141	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MYC—esophageal cancer	9.02e-05	0.000135	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CA—esophageal cancer	8.83e-05	0.000132	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTGS2—esophageal cancer	8.59e-05	0.000129	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CA—esophageal cancer	8.45e-05	0.000126	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—EP300—esophageal cancer	7.15e-05	0.000107	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CA—esophageal cancer	5.29e-05	7.91e-05	CbGpPWpGaD
